Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 494 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 76-100 of 468 matching filings.

Per page
25
Current page
4
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Jul 2022
Reporting date
01 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
29 Jun 2022
Reporting date
28 Jun 2022
Next action
Verify source filing
424B3 File 333-242322

PROSPECTUS SUPPLEMENT

Filing date
28 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
13 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
13 Apr 2022
Reporting date
07 Apr 2022
Next action
Verify source filing
10-K File 001-36374

ANNUAL REPORT

Filing date
25 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
12 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
09 Nov 2021
Reporting date
09 Nov 2021
Next action
Verify source filing
DEFA14A File 001-36374

DEFA14A

Filing date
05 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36374

DEFINITIVE PROXY STATEMENT

Filing date
18 Oct 2021
Reporting date
09 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
23 Sep 2021
Reporting date
22 Sep 2021
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
30 Jul 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
14 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
10-K File 001-36374

ANNUAL REPORT

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82467

SABBY 13G-A ATNM 1.05.21

Filing date
05 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .